The impact of cross-reactive immunity on the probability that a newly introduced SARS-CoV-2 variant will invade the host population
Frontiers | Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination | Science
The known unknowns of T cell immunity to COVID-19 | Science Immunology
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models: Molecular Therapy - Methods & Clinical Development
Heterologous immune exposures activate T cells cross-reactive for... | Download Scientific Diagram
Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine
Viruses | Free Full-Text | Quantifying T Cell Cross-Reactivity: Influenza and Coronaviruses
Cross-reactivity of Antibody: Beneficial or Harmful? - Cusabio
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial - The Lancet
BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination | Science
The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants - WRAP: Warwick Research Archive Portal
Cells | Free Full-Text | Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
The expanding realm of heterologous immunity: friend or foe? - Page - 2006 - Cellular Microbiology - Wiley Online Library
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans - ScienceDirect
SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity | Signal Transduction and Targeted Therapy
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection | Nature Immunology
Frontiers | Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 - ScienceDirect
